Log in or Sign up for Free to view tailored content for your specialty!
Hepatitis C News
VIDEO: HCV elimination efforts must focus on health disparities
BOSTON — In this video, John W. Ward, MD, spoke with Healio about two presentations from The Liver Meeting that highlighted ways to overcome health disparities among patients with hepatitis C virus infection.
VIDEO: Access to generic DAA treatment critical for HCV elimination
BOSTON — Treatment of hepatitis C virus infection in low- and middle-income countries is key to global elimination efforts, according to an abstract presented at The Liver Meeting.
Log in or Sign up for Free to view tailored content for your specialty!
VIDEO: Risk for cancer, other events remains after cure for HCV-related cirrhosis
BOSTON — Patients with hepatitis C virus-related cirrhosis who achieve sustained virologic response remain at risk for cancer, as well as other non-liver-related events such as diabetes, according to an abstract presented at The Liver Meeting.
‘Significant gaps’ reported in testing, treatment among pregnant people with HCV
BOSTON — Researchers found “significant gaps” in follow-up testing and treatment among a cohort of pregnant individuals in Canada with a diagnosis of hepatitis C virus infection, according to data presented at The Liver Meeting.
No-cost HCV treatment trial reduces community viral load in rural Kentucky county
BOSTON — A treatment trial that recruited individuals chronically infected with hepatitis C virus and provided no-cost medical care helped reduce the proportion of viremic individuals in a rural Appalachian county, data showed.
Sofosbuvir-based regimens demonstrate durable SVR in children with HCV
BOSTON — Treatment with sofosbuvir-based direct-acting antivirals demonstrated durable sustained virologic response up to 5 years among pediatric patients with hepatitis C virus, according to findings presented at The Liver Meeting.
No increased risk for COVID-19 related mortality associated with HCV alone
BOSTON — In the absence of cirrhosis, no specific precautions are needed for patients with SARS-CoV-2 infection and a history of hepatitis C virus, according to findings presented at The Liver Meeting.
Sofosbuvir/velpatasvir with tenofovir alafenamide efficacious for HCV, HBV co-infection
BOSTON — After 12 weeks of treatment with sofosbuvir/velpatasvir in combination with tenofovir alafenamide, patients with hepatitis C virus and hepatitis B virus co-infection demonstrated high rates of sustained virologic response.
Direct-acting antiviral use remains low, despite improved survival in HCV-related HCC
BOSTON — Direct-acting antiviral therapy for hepatitis C virus-related hepatocellular carcinoma significantly improves overall survival, but only one in four patients receive therapy, even with insurance, according to a researcher.
Q&A: CDC recommends testing all children exposed to hepatitis C
The CDC this week recommended hepatitis C testing for all infants or children who were perinatally exposed to the virus by a pregnant person with a current or probable HCV infection.
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read